GLOBAL PHARMATECH RECEIVES SFDA APPROVAL FOR THREE NEW BOTANICAL DRUG PRODUCTS

Global Pharmatech, Inc. (OTC PK: GBLP) announced today that its majority-owned subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China. The approvals allow for its botanical drugs products, Jin Lian Hua Capsule, Gong

Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-05-2005/0004227595&EDATE=)